DNAJA1 and cancer: Since mutp53 increases radio- and chemotherapy-resistance [80,81,82,83], treatments of cancer cells carrying misfolded/conformational mutp53 with a DNAJA1/HDJ2 inhibitor may effectively increase the sensitivity to radio- and chemotherapies.